AKE-16180-58911
3 vaccinations
5 coded responses
31 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 917 / CA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Registered in v-safe
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-25
- 2021-01-01
- 2021-01-08
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-12
- 2021-01-16
- 2021-01-25
- 2021-02-07
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-28
Dose 3 — Pfizer-BioNTech
- 2021-09-28
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
-
2021-10-06
Survey response — day 7, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: Pregnancy positiveMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Survey response — day 14, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: Pregnancy confirmed - associated early pregnancy symptomsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Survey response — day 21, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-26
- 2021-11-02
- 2021-11-11
- 2021-11-11
-
2022-03-29
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnancy with nausea/vomiting x 6 weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-30
-
2022-09-28
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-19 | Unsuccessful | |
| 2022-03-29 | Unsuccessful |
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): Pregnancy positive
Release 10 — day 14, dose 3
Symptoms: Pregnancy confirmed - associated early pregnancy symptoms
Release 10 — day 21, dose 3
Symptoms: Miscarriage
Release 11 — 6 months, dose 3
Symptoms: Pregnancy with nausea/vomiting x 6 weeks
Release 12 — 12 months, dose 3
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release